SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-161647
Filing Date
2017-05-08
Accepted
2017-05-08 06:07:54
Documents
58
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d372324d10q.htm 10-Q 568253
2 EX-31.1 d372324dex311.htm EX-31.1 6526
3 EX-31.2 d372324dex312.htm EX-31.2 6574
4 EX-32.1 d372324dex321.htm EX-32.1 3994
11 GRAPHIC g372324g0505073050484.jpg GRAPHIC 26862
12 GRAPHIC g372324g77l56.jpg GRAPHIC 128335
  Complete submission text file 0001193125-17-161647.txt   2992586

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT epzm-20170331.xml EX-101.INS 413100
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20170331.xsd EX-101.SCH 34861
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20170331_cal.xml EX-101.CAL 47836
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20170331_def.xml EX-101.DEF 98677
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20170331_lab.xml EX-101.LAB 292011
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20170331_pre.xml EX-101.PRE 200979
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 17820398
SIC: 2834 Pharmaceutical Preparations